Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy



Status:Completed
Conditions:Diabetic Neuropathy, Neurology, Diabetes, Pain
Therapuetic Areas:Endocrinology, Musculoskeletal, Neurology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:December 2012
End Date:July 2013

Use our guide to learn which trials are right for you!

Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)

The difference between active treatment and placebo in a clinical trial of an analgesic
appears to depend on a variety of factors other than the actual efficacy of the drug itself,
including various aspects of study design and conduct. One potential such factor is how
information about the study is presented to research staff and patients. The purpose of this
study is to examine the impact of different presentations of information on the difference
between pregabalin and placebo observed in a clinical trial in patients with painful
diabetic neuropathy.


Inclusion Criteria:

- Willingly signs and dates an Informed Consent Form (ICF) that is approved by an
Institutional Review Board/Independent Ethics Committee (IRB/IEC), prior to the
conduct of any study-specific procedures;

- Is at least 18 years old;

- Has a diagnosis of type 1 or type 2 diabetes and painful distal symmetric
sensorimotor polyneuropathy;

- Has experienced a minimum duration of PDN of at least 6 months;

- Is on stable diabetic medication that is not expected to change during the study;

- Has a worst pain intensity over the past 24 hours as a 4 or higher on a 0-10
numerical rating scale at Screening;

- And is able to read and communicate meaningfully in English and comply with all study
procedures

Exclusion Criteria:

- Has a psychiatric or psychological disorder that in the judgment of the Investigator
would interfere with the completion of the study, confound the study results, or pose
subject risk;

- Has an uncontrolled, clinically significant medical condition that in the judgment of
the Investigator may contraindicate use of pregabalin or participation in the study
(e.g., hepatic, respiratory, or hematologic illness; cardiovascular disease; or
symptomatic peripheral vascular disease);

- Has experience as an investigator or a study staff member in clinical trials research
in a role that involved direct patient contact;

- Participated in any of the following studies: Analgesic Solutions Protocol #
ALPMF.SOW.0007, Analgesic Solutions Protocol # ALPMF.SOW.0007.02, or Astellas
Protocol # E05-CL-3004;

- Has pain of other origin that might confound assessment of PDN;

- Has major skin ulceration;

- Has had an amputation other than toes;

- Has a history of suicide attempt within the past 1 year;

- Reports current suicidal ideation within the past 1month;

- Has history of kidney disease that is likely to decrease creatinine clearance;

- Has creatinine clearance below 60 as calculated by Cockroft-Gault equation for serum
creatinine;

- Has a history of drug or alcohol abuse within the past 1 year;

- Has hypersensitivity, intolerance, or allergy to pregabalin or gabapentin;

- Subject is pregnant, is considering becoming pregnant during the study, is
breastfeeding or unwilling to use adequate birth control during the study;

- Participated in another clinical trial within the past month;

- Is involved in an ongoing or settled worker's compensation claim, disability, or
litigation;

- Has a known failure to respond to pregabalin or gabapentin at a clinically relevant
dose due to either efficacy or tolerability;

- Or has taken opioids on an as-needed basis within 1week of Screening, or has taken
pregabalin or gabapentin within 30 days of screening. Subjects on stable doses
opioids, antidepressants, non-steroidal anti-inflammatory drugs, or low-dose aspirin
will be allowed to participate in the study
We found this trial at
6
sites
Johnson City, New York 13790
?
mi
from
Johnson City, NY
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
Altoona, Pennsylvania 16602
?
mi
from
Altoona, PA
Click here to add this to my saved trials
Brighton, Massachusetts 02135
?
mi
from
Brighton, MA
Click here to add this to my saved trials
Johnston, Rhode Island 02919
?
mi
from
Johnston, RI
Click here to add this to my saved trials
Watertown, Massachusetts 02472
?
mi
from
Watertown, MA
Click here to add this to my saved trials